Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.64 |
| ▸ | NPC1 | O15118 | 7/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2518498 | 0.89 | LMNA (0.63) | RAB9ANPC1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL30037937 | 0.86 | RAB9A (0.62) | RAB9ANPC1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL757031 | 0.86 | RAB9A (0.62) | RAB9ANPC1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL1374759 | 0.85 | NPC1 (0.71) | RAB9ANPC1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL285358 | 0.84 | RAB9A (0.60) | RAB9ANPC1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL243922 | 0.84 | LMNA (0.61) | RAB9ANPC1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL2929122 | 0.84 | MAPT (0.66) | RAB9ANPC1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL14050118 | 0.84 | MAPT (0.76) | RAB9ANPC1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL103809 | 0.84 | RAB9A (0.60) | RAB9ANPC1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL104281 | 0.84 | HDAC6 (0.61) | RAB9ANPC1SMN1; SMN2LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2527404-B1 | COMPOSITION FOR ULTRAVIOLET RAY-ABSORBABLE MEMBER, AND ULTRAVIOLET RAY-ABSORBABLE MEMBER COMPRISING SAME | SUMITOMO SEIKA CHEMICALS (JP) | 2019-05-29 | — | — | EP | disclosed |
| US-8680274-B2 | Bent allenes, and their metal complexes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-03-25 | — | — | US | disclosed |
| US-8540904-B2 | Composition for ultraviolet absorbent substance and ultraviolet absorbent substance comprising same | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2013-09-24 | — | — | US | disclosed |
| US-20120313058-A1 | COMPOSITION FOR ULTRAVIOLET ABSORBENT SUBSTANCE AND ULTRAVIOLET ABSORBENT SUBSTANCE COMPRISING SAME | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2012-12-13 | — | — | US | disclosed |
| US-20110021775-A1 | BENT ALLENES, AND THEIR METAL COMPLEXES | NATIONAL SCIENCE FOUNDATION | 2011-01-27 | — | — | US | disclosed |
| WO-2009089483-A1 | BENT ALLENES, AND THEIR METAL COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021775-A1 | BENT ALLENES, AND THEIR METAL COMPLEXES | NBAS, AP1M1, SOD1 | RAB9A 1957/4885NPC1 1010/4885SMN1; SMN2 1618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.